These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10987101)

  • 1. [The experimental validation of the advantages of combined emergency (fluoroquinolones) and specific (EV Nalr) prevention of plague versus their sequential use].
    Ryzhko IV; Tsuraeva RI; Samokhodkina ED; Shcherbaniuk AI; Mishan'kin BN; Koroleva NS; Anisimov BN
    Antibiot Khimioter; 2000; 45(7):10-3. PubMed ID: 10987101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of outcomes of combined specific prophylaxis with the antibiotic resistant immunogenic plague pathogen strain and emergency prophylaxis with aminoglycosides in the experimental plague model in white mice].
    Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI; Shut'ko AG
    Antibiot Khimioter; 2003; 48(5):15-9. PubMed ID: 12968464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylactic use of ceftriaxone in combination with F I antigen immunization in studies on uninbred albino mice infected by Yersinia pestis. Antiplague immunity development].
    Ryzhko IV; Moldavan IA; Tsuraeva RI; Shcherbaniuk AI
    Antibiot Khimioter; 2006; 51(9-10):8-12. PubMed ID: 18030785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].
    Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV
    Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of plague prophylaxis with streptomycin, tetracycline, and rifampicin in simultaneous immunization of white mice by resistant EV NRIEG strain].
    Ryzhko IV; Tsuraeva RI; Moldavan IA; Shcherbaniuk AI
    Antibiot Khimioter; 2004; 49(1):17-21. PubMed ID: 15164519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Formation of virulent antigen-modified mutants (Fra-, Fra-Tox-) of plague bacteria resistant to rifampicin and quinolones].
    Ryzhko IV; Shcherbaniuk AI; Skalyga EIu; Tsuraeva RI; Moldavan IA
    Antibiot Khimioter; 2003; 48(4):19-23. PubMed ID: 13677133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
    Ryzhko IV; Trishina AV; Verkina LM
    Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
    DeBord KL; Anderson DM; Marketon MM; Overheim KA; DePaolo RW; Ciletti NA; Jabri B; Schneewind O
    Infect Immun; 2006 Aug; 74(8):4910-4. PubMed ID: 16861680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infectious-toxic model of plague in mice].
    Ryzhko IV; Mishan'kin BN; Tsuraeva RI; Shcherbaniuk AI; Anisimov BI
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):46-50. PubMed ID: 19621819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The evaluation of the efficacy of immunization against plague by the modulation in the index of the macrophagal transformation of of the peripheral blood monocytes].
    Verkina LM; Vasil'eva GI; Kiseleva AK; Moskalenko VI
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):53-5. PubMed ID: 9082730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A method of assessing immunogenicity of preparations for plague prevention].
    Vasil'eva GI; Doroshenko EP; Kiseleva AK; Bespalova IA
    Klin Lab Diagn; 1999 Mar; (3):37-9. PubMed ID: 10234932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience using fraction I of the plague microbe for revaccinating experimental animals].
    Lebedinskiĭ VA; Chicherin IuV; Pautov VN; Evstigneev VI; Byvalov AA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):60-3. PubMed ID: 7102182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of new quinolones in experimental aerogenic plague infection of albino mice].
    Shcherbaniuk AI; Lozovoĭ NV; Kasatkina IV; Pasiukov VV
    Antibiot Khimioter; 1994 Jun; 39(6):13-4. PubMed ID: 7847999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague.
    Levy Y; Flashner Y; Tidhar A; Zauberman A; Aftalion M; Lazar S; Gur D; Shafferman A; Mamroud E
    Vaccine; 2011 Sep; 29(40):6866-73. PubMed ID: 21803090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of T-suppressors in the formation of plague immunity in mice].
    Nazarova LS; Isupov IV; Surikov NN; Piontkovskiĭ SA; Devdariani ZL; Golubeva II; Taranenko TM; Alenkina TV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):89-93. PubMed ID: 2143614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.
    Honko AN; Sriranganathan N; Lees CJ; Mizel SB
    Infect Immun; 2006 Feb; 74(2):1113-20. PubMed ID: 16428759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a Cynomolgus Macaque Model of Pneumonic Plague for Evaluation of Vaccine Efficacy.
    Fellows P; Price J; Martin S; Metcalfe K; Krile R; Barnewall R; Hart MK; Lockman H
    Clin Vaccine Immunol; 2015 Sep; 22(9):1070-8. PubMed ID: 26224691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen].
    Samokhodkina ED; Shcherbaniuk AI; Ryzhko IV; Tsuraeva RI; Skalyga EIu
    Antibiot Khimioter; 2002; 47(3):26-9. PubMed ID: 16127904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immunological responses of plague vaccines F1+rV270 and EV76 in Chinese-origin rhesus macaque, Macaca mulatta.
    Qiu Y; Liu Y; Qi Z; Wang W; Kou Z; Zhang Q; Liu G; Liu T; Yang Y; Yang X; Xin Y; Li C; Cui B; Huang S; Liu H; Zeng L; Wang Z; Yang R; Wang H; Wang X
    Scand J Immunol; 2010 Nov; 72(5):425-33. PubMed ID: 21039737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.